Hypernatremia, defined as an elevation of serum sodium \>145 mEq/L, is one of the most common electrolyte disturbances in hospitalized patients and intensive care units. In this study, the investigator aims, for the first time, to compare two strategies used for the correction of hypernatremia, using intravenous hypotonic solution compared to naso- or orogastric tube enteral water.
Hypernatremia, defined as an elevation of serum sodium \>145 mEq/L, is one of the most common electrolyte disturbances in hospitalized patients and intensive care units, increasing mortality. Currently, the most effective correction strategy for hypernatremia (intravenous hypotonic solution compared to enteral water) is still a matter of debate due to a lack of evidence and clinical trials. This study aims to determine whether the administration of intravenous hypotonic solution is more effective in the correction of hypernatremia compared to enteral water by naso- or orogastric tube. Therefore, the investigator proposes the first randomized clinical trial, which compares two strategies used for the correction of hypernatremia, with this we will determine which of the two is more effective, and we will also compare the speed of correction, renal function during hospitalization with serum creatinine and we will evaluate its safety.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
178
Intravenous administration of 5% glucose solution 1,200ml every 8 hours for a total of 3,600ml per day. If hyperglycemia is present, it will be glucose solution 5% 500ml + injectable water 500ml intravenous every 8 hours for a total of 3,600ml daily.
administration of bottled water through the nasogastric or orogastric tube at a dose of 150 ml/hour for a total of 3,600 ml per day.
The efficiency of intravenous hypotonic solution for the correction of hypernatremia compared with enteral water.
Correction of hypernatremia is \<145mEq/L serum sodium
Time frame: every 12 hours during the first 48hrs of treatment and then every 24 hours for the first 5 days of the study.
mortality
Time frame: the first 5 days of the study
renal function
serum creatinine
Time frame: the first 5 days of the study
volume overload
volume overload determined by accumulated water balance in milliliters
Time frame: the first 5 days of the study
neurological alterations
neurological disorders defined as the presence of altered state of consciousness, seizures and/or cerebral edema
Time frame: the first 5 days of the study
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.